4,6-Dibromobenzo[d]thiazol-2-amine, 95.0%, 5g

3-(Benzo[d]thiazol-2-yl)-4,5,6,7-tetrahydrobenzo[b]thiophen-2-amine, 95.0%, 2.5g

1-cyclopentyl-4-[(methylamino)methyl]-2-pyrrolidinone - carbonic acid (1:1), 95.0%, 25g

2-(3-Bromophenyl)-1,3,4-oxadiazole, 95+%, 1g

3H-Pyrimido[5,4-b]indol-4(5H)-one, 95.0%, 100mg

1-(4-Aminophenyl)pyrrolidin-3-ol, 95%, 1g

(3-Bromo-2-chloro-pyridin-4-yl)-carbamic acid tert-butyl ester, 98%, 250mg

N,N-Dimethylpropanethioamide, 95.0%, 5g

2,3-Difluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 97%, 5g

6-Fluoro-1-methyl-1H-benzo[d]imidazole, 95.0%, 1g

tert-Butyl ((2S,3R)-2-methyl-4-oxooxetan-3-yl)carbamate, 98%, 10mg

Flacons à fond rond à trois cols cols latéraux parallèles, 3000 ml, 29/32, 29/32, 1 pièce

8-((1R,2R)-2-Hydroxy-2-methylcyclopentyl)-2-(methylthio)pyrido[2,3-d]pyrimidin-7(8H)-one, 97%, 50mg